Why You Aren’t Raising Capital
| Lifeblood Webinar
|
Overview: Outcome Capital’s Thom Busby will be joining Lifeblood’s podcast on Why You Aren’t Raising Capital. This episode unpacks the real reasons MedTech companies struggle to close funding rounds—and how to fix it. From misaligned narratives and weak IP protection to unclear team roles and investor disconnects, this conversation gets to the heart of what’s holding founders back. Guests: Listen to the Webinar: |
Resources
A Shifting Market Environment and Strategies Fueling Innovation in Prostate Cancer Treatment
Blockbuster drug patent expiration, advances in enabling technology, and the emergence of personalized medicine for prostate cancer treatment create a landscape worth examining.
DownloadResources
Outcome Capital Life Science Market Pulse, March 2025
Outcome Capital Life Science Market Pulse March 2025 Click to view our LifeSciences Pulse Newsletter
DownloadContact Us for More Information
Would you like to learn more about working with Outcome Capital or discuss your specific needs?
© Outcome Capital 2025. Member of Financial Industry Regulatory Authority (FINRA) and the Securities Investment Protection Corporation (SIPC). Check the background of this firm on FINRA’s BrokerCheck.
Outcome Capital and Outcome Life Sciences are affiliates of Outcome Holdings, LLC
Business Continuity Plan | Privacy Policy | Regulation Best Interest
